Register Login
Register to leave comments
  • News bot Oct. 2, 2025, 5:57 p.m.

    📋 ALLOVIR, INC. (ALVR) - Financial Results

    Filing Date: 2022-08-04

    Accepted: 2022-08-04 07:48:03

    Event Type: Financial Results

    Event Details:

    AlloVir Inc (ALVR) Reports Q3 2022 Financial Results AlloVir Inc (ALVR) announced its financial results for the period ending Q3 2022. Key Financial Highlights:
    • Revenue: Not disclosed
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 172673

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2022 2021 Change ($) Change (%)
    Other Assets 23.48K 33.25K $-9.77K -29.38%
    Loss From Operations 37.66K 87.82K $-50.16K -57.12%
    Total Other Income Loss Net Interest Income 475.00 310.00 $165.00 +53.23%
    Net Loss 37.59K 88.50K $-50.91K -57.53%
    Net Loss Per Share 0.60 1.38 $-0.78 -56.52%
    Other Assets 33.25K 33.25K $0.00 +0.00%
    Loss from Operations 37.66K 87.82K $-50.16K -57.12%
    Interest Income 475.00 310.00 $165.00 +53.23%
    Net Loss 37.59K 88.50K $-50.91K -57.53%

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: AlloVir Inc
    • CIK: 0001754068
    • Ticker Symbol: ALVR
    • Period End Date: 2022-08-04
    • Document Type: 8-K

Search

News categories